Galectin-1 is inversely associated with type 2 diabetes independently of obesity – A SCAPIS pilot study
Objectives: Galectin-1 is a recently discovered adipokine that increases with obesity and increased energy intake in adipose tissue. Our aim was to assess whether serum galectin-1 is associated with type 2 diabetes (T2D) and other parameters of the metabolic syndrome independently of body mass index...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-12-01
|
Series: | Metabolism Open |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589936819300179 |